SciSparc jumps 150.8% as subsidiary wins conditional exchange approval for CliniQuantum deal

By: Quiver PriceTracker

Posted: 53 minutes ago / May 28, 2026 5 p.m. UTC

SPRC

SciSparc Ltd. (SPRC) is up 150.8% today. Here is some analysis on what might have caused this price movement.

Analysis: Shares appear to be reacting to SciSparc’s announcement that its majority-owned subsidiary NeuroThera received conditional approval from the TSX Venture Exchange related to NeuroThera’s planned acquisition of a majority stake in CliniQuantum. The update likely signaled improved odds of closing and reignited speculative interest given SPRC’s small-cap profile and recent volatility.

Details:

SciSparc disclosed that NeuroThera received conditional TSX Venture Exchange approval for the acquisition of roughly 54% of CliniQuantum Ltd.

The transaction structure involves NeuroThera issuing 56,600,000 shares to acquire 56,375 CliniQuantum shares, with the consideration value referenced off NeuroThera’s 20-day volume-weighted average price.

The company also noted an amended agreement that included an updated floor price for certain earn-out shares and an extended outside closing date (subject to conditions and required approvals).

Separately, SciSparc highlighted ongoing intellectual property activity at NeuroThera, which may have added to bullish sentiment.

Sources:

GlobeNewswire, U.S. SEC (EDGAR), Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive SPRC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$SPRC Hedge Fund Activity

We have seen 0 institutional investors add shares of $SPRC stock to their portfolio, and 8 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG removed 22,542 shares (-87.8%) from their portfolio in Q1 2026, for an estimated $82,503
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC removed 20,224 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $74,019
XTX TOPCO LTD removed 10,331 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $37,811
BANK OF AMERICA CORP /DE/ removed 1,366 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,857
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL removed 1,067 shares (-88.9%) from their portfolio in Q1 2026, for an estimated $3,905
VALLEY NATIONAL ADVISERS INC removed 1,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,360
SBI SECURITIES CO., LTD. removed 10 shares (-90.9%) from their portfolio in Q1 2026, for an estimated $36

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.